関連ピューリンヌクレオシドフォスフォリレーゼによる移行状態のアナログ差別
Erika A Taylor Ringia1, Peter C Tyler, Gary B Evans
1Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
Journal of the American Chemical Society
|June 1, 2006
まとめ
移行状態のアナログであるImucillinsとDADMe-Immucillinsは, purin nucleoside phosphorylase (PNP) 酵素のために設計されました. 移行状態の幾何学を模倣することで,人間のPNPと牛のPNPの活性部位が保存されているにもかかわらず,結合親和性を成功裏に区別することができました.
科学分野:
- バイオケミストリー バイオケミストリー
- 酵素阻害は酵素を抑制する.
- 構造生物学 構造生物学とは
背景:
- ピューリン核酸塩リン酸化酵素 (PNP) は,ピューリン代謝の重要な酵素である.
- PNPの特定の阻害剤の開発は,治療用途において極めて重要です.
- 移行状態における酵素基板相互作用を理解することは,阻害剤の設計に不可欠です.
研究 の 目的:
- PNPのトランジション状態アナログ,特にインムシリンとDADMe-インムシリンを設計・合成する.
- 人間のPNPと牛のPNPとの間に拘束力のある親和差別の授与における移行状態ミミクリの役割を調査する.
- 阻害剤の構造特性を,その結合特性と相関させる.
主な方法:
- インムシリンとDADMe-インムシリンの設計は,牛とヒトのPNPの移行状態のアナログとして.
- 特定の基質機能群 (ヒドロキシルおよびヒドロキシメチル) を含むまたは含まない阻害剤変異体の合成.
- PNP-リガンド複合体の結晶学分析により,活性部位の保存を決定する.
主要な成果:
- 移行状態の幾何学を模倣するように設計された阻害剤は,有意な結合親近性差別を示した.
- 阻害剤に含まれるヒドロキシルおよびヒドロキシメチル基の存在または欠如は,結合親和性に影響を及ぼした.
- 結晶学的データは,ヒトおよび牛のPNPにおける活性部位残留およびリガンド接触の完全な保存を明らかにした.
結論:
- 移行状態の幾何学は,PNP阻害における結合親和差別の達成のための重要な決定因子である.
- 保存された活性部位であっても,移行状態の特徴に基づいた微妙な阻害剤設計は,選択的結合を生成することができます.
- これらの発見は,標的型治療のための高度に特異的なPNP阻害剤の開発のための基盤を提供します.
関連する概念動画
Proofreading
Synthesis of new DNA molecules starts when DNA polymerase links nucleotides together in a sequence that is complementary to the template DNA strand. DNA polymerase has a higher affinity for the correct base to ensure fidelity in DNA replication. The DNA polymerase furthermore proofreads during replication, using an exonuclease domain that cuts off incorrect nucleotides from the nascent DNA strand.Errors during Replication Are Corrected by the DNA Polymerase EnzymeGenomic DNA is synthesized in...
DNA Base Pairing
Erwin Chargaff’s rules on DNA equivalence paved the way for the discovery of base pairing in DNA. Chargaff’s rules state that in a double-stranded DNA molecule,
Allosteric Proteins-ATCase
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Proofreading
Synthesis of new DNA molecules is carried out by the enzyme DNA polymerase, which adds nucleotides on the daughter strand complementary to the template DNA strand. DNA polymerase has a higher affinity to add the correct base and ensures fidelity during DNA replication. Furthermore, it exhibits proofreading activity during replication, using an exonuclease domain that cuts off incorrect nucleotides from the nascent DNA strand.
Errors During Replication are Corrected by the DNA Polymerase Enzyme
Errors During Replication are Corrected by the DNA Polymerase Enzyme
Biosynthesis of Nucleic Acids
Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...


